首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1481076篇
  免费   122969篇
  国内免费   6703篇
耳鼻咽喉   18735篇
儿科学   47698篇
妇产科学   39621篇
基础医学   203204篇
口腔科学   43186篇
临床医学   131379篇
内科学   310106篇
皮肤病学   35454篇
神经病学   122598篇
特种医学   60058篇
外国民族医学   294篇
外科学   228205篇
综合类   32693篇
现状与发展   3篇
一般理论   465篇
预防医学   122081篇
眼科学   30775篇
药学   102515篇
  5篇
中国医学   2831篇
肿瘤学   78842篇
  2019年   12064篇
  2018年   17581篇
  2017年   13739篇
  2016年   15730篇
  2015年   17740篇
  2014年   24688篇
  2013年   35733篇
  2012年   45655篇
  2011年   48721篇
  2010年   29301篇
  2009年   28307篇
  2008年   43919篇
  2007年   46877篇
  2006年   47362篇
  2005年   46239篇
  2004年   44002篇
  2003年   42453篇
  2002年   38758篇
  2001年   69825篇
  2000年   71723篇
  1999年   60007篇
  1998年   18000篇
  1997年   16091篇
  1996年   17040篇
  1995年   17092篇
  1994年   15919篇
  1993年   14849篇
  1992年   49128篇
  1991年   47771篇
  1990年   45801篇
  1989年   43634篇
  1988年   40398篇
  1987年   39576篇
  1986年   37335篇
  1985年   36027篇
  1984年   27389篇
  1983年   22934篇
  1982年   14307篇
  1981年   12863篇
  1980年   12129篇
  1979年   24319篇
  1978年   17549篇
  1977年   14782篇
  1976年   13514篇
  1975年   14180篇
  1974年   16525篇
  1973年   15855篇
  1972年   14569篇
  1971年   13393篇
  1970年   12277篇
排序方式: 共有10000条查询结果,搜索用时 531 毫秒
31.
32.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
33.
34.
35.
Metabolism describes the series of chemical reactions that are concerned with the provision of energy to biological systems. They may be divided into reactions involved in energy yield (catabolism: demand exceeds supply), and energy storage (anabolism: supply exceeds demand). Regulation of these pathways is critical for homeostasis, and derangements in metabolism are seen in a wide variety of pathological processes. Understanding metabolism is key to the treatment of many diseases, notably diabetes, as well as underpinning clinical nutritional support.  相似文献   
36.
Depigmented lesions may occur as postinflammatory sequelae of subacute cutaneous lupus erythematosus (SCLE), leading to great psychosocial impact. A 53‐year‐old male patient presented with post‐SCLE depigmented facial lesions after five years of disease stability. We proposed surgical treatment with melanocyte‐keratinocyte transplantation procedure (MKTP), and after five months the patient achieved 90% repigmentation, without Koebner phenomenon (KP). In theory, KP is a possible complication of MKTP procedure since the preparation of the receptor area involves the use of dermabrasion. In an attempt to avoid it, we suggest to maintain the treatment of the underlying disease and wait for a minimum period of disease stability before the procedure.  相似文献   
37.
38.
39.
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号